IGAP

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 8/29/2017
Contact Info
  • 19 Ha Yahalomim St.
  • P.O. Box 12163
  • Ashdod 7760049
  • Israel

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001506983
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: DE, USA
Year of Inc. 2001
Employees 37 a/o Dec 22, 2013
Company Officers/Contacts
John Graham CEO
Sami Sassoun CFO
David Malka VP, Ops.
David Podwalski Chief Commercial Officer
Company Directors
John Graham Chairman
Robert Fischell
Revan Schwartz
Leslie Seff
Angela Strand
Service Providers
Accounting/Auditing Firm
Grant Thornton Israel
Levinstein Tower
23 Menachem Begin Road
Tel Aviv, Israel

Legal Counsel
Greenberg Traurig LLP
333 2nd Avenue
Miami, FL, 33131
United States

Investor Relations Firm
Not Available
IGAP Security Details
Share Structure
Market Value1 $25,524,596 a/o Sep 25, 2017
Authorized Shares 40,000,000 a/o Sep 30, 2016
Outstanding Shares 6,381,149 a/o Aug 15, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Shareholders
Shareholders of Record 307 a/o Mar 31, 2017
Short Selling Data
Short Interest 3,316 (563.2%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security